Reuters logo
BRIEF-Melinta Therapeutics skin infection drug wins U.S. FDA approval
June 19, 2017 / 8:43 PM / 6 months ago

BRIEF-Melinta Therapeutics skin infection drug wins U.S. FDA approval

June 19 (Reuters) -

* Melinta Therapeutics announces U.S. FDA approval of baxdela™ (delafloxacin) for acute bacterial skin and skin structure infections (absssi) Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below